Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Epithelial growth factor receptor (EGFR) exon double-sequencing analysis in NSClC].

Zhonghua zhong liu za zhi [Chinese journal of oncology] - 1 Aug 2006

Lai Ren-sheng, Xie Ling, Shen Long-shu, Zhu Chang-le, Qian Jun

Abstract excerpt

OBJECTIVE: To study the mutation patterns of epithelial growth factor receptor (EGFR) exon 18, 19 and 21 in Chinese non-small-cell lung cancers (NSCLC). METHODS: Somatic mutation in samples of 32 cases without Iressa-treatment were compared with that in 10 volunteers blood control. The mutations...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Asian People
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA Mutational Analysis

Share to ErbB Receptors

Share to Lung Neoplasms

Source

Identifiers

PMID: 17236554

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-17236554-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Epithelial growth factor receptor (EGFR) exon double-sequencing analysis in NSClC].PMID 17236554Read ↗

[Analysis of EGFR mutations in 176 cases of non-small cell lung cancer].Semantic proximity Read ↗

[Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].Semantic proximity Read ↗

[Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].Semantic proximity Read ↗

[EGFR gene mutation status among lung cancer patients in China].Semantic proximity Read ↗

[Detection of epidermal growth factor receptor gene mutations and its clinical significance in non-small cell lung cancers].Semantic proximity Read ↗

[Mutational analysis of EGFR and K-RAS in Chinese patients with non-small cell lung cancer].Semantic proximity Read ↗

[Mutations in exon 19 of EGFR gene in non-small cell lung cancer from Chinese patients].Semantic proximity Read ↗

[Epidermal growth factor receptor gene mutations and clinicopathologic correlation in 309 patients with non-small cell lung cancer].Semantic proximity Read ↗

[Relationship between EGFR and K-ras mutations and clinicopathological characteristics and response to erlotinib treatment in 301 Chinese patients with non-small cell lung cancer].Semantic proximity Read ↗

[Epidermal growth factor receptor mutation in non-small cell lung cancer and breast cancer].Semantic proximity Read ↗

Patients with non‑small cell lung cancer with the exon 21 L858R mutation: From distinct mechanisms to epidermal growth factor receptor tyrosine kinase inhibitor treatments (Review)Semantic proximity Read ↗

Epidermal growth factor receptor double activating mutations involving both exons 19 and 21 exist in Chinese non-small cell lung cancer patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.